Jeffrey E. Jacob - 04 Oct 2022 Form 4 Insider Report for Panbela Therapeutics, Inc. (PBLA)

Role: Director
Signature: /s/ Joshua L. Colburn, Attorney-in-Fact
Issuer symbol: PBLA
Transactions as of: 04 Oct 2022
Net transactions value: $0
Form type: 4
Filing time: 06 Oct 2022, 17:24:00 UTC
Previous filing: 27 Jun 2022
Next filing: 29 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PBLA	Common Stock	Purchase		+33,000	+13%		294,931	04 Oct 2022	Direct	F1
holding	PBLA	Common Stock						17,771	04 Oct 2022	Jointly with spouse
holding	PBLA	Common Stock						54,374	04 Oct 2022	By trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PBLA	Warrants (right to buy)	Purchase	$0	+49,500		$0.000000	49,500	04 Oct 2022	Common Stock	49,500	$0.3000	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reported securities purchased as one share of common stock and one warrant to purchase one share of common stock for a combined price of $0.30 per share and warrant.